Pacira BioSciences Inc (PCRX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

5 SYLVAN WAY PARSIPPANY, NJ 07054

Pacira Pharmaceuticals, Inc., a pharmaceutical company, engages in the development, commercialization, and manufacture of pharmaceutical products for hospitals and ambulatory surgery centers. It provides its pharmaceutical products based on DepoFoam drug delivery technology.

Data as of 2020-06-27
Market Cap1.857 Billion Shares Outstanding42.121 Million Avg 30-day Volume593.091 Thousand
P/E Ratio Dividend Yield EPS-0.02
Price/Sales4.265 Price cash flow ratio25.9 Price free cash flow ratio-31.3
Book Value8.88 Price to Tangible Book11.08 Alpha-0.01
Short Interest Ratio % Short Interest to Float R-squared0.152089
BETA1.2771 52-week High/Low51.3525 / 27.46 Stddev0.139706
View SEC Filings from PCRX instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 4 4 (0.26%)
13F Filers holding this stock: 221 68 (4.45%)
Aggregate 13F shares on 03/31/2020: 46.417 Million 22.63 Million
Aggregate 13F shares on 12/31/2019: 45.459 Million 19.642 Million
Percent change: 2.11% 15.21%
Funds creating new positions: 35 12
Funds Adding to an existing position: 83 26
Funds closing out their position: 39 16
Funds reducing their position: 69 22
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding PCRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PCRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

120.4 Thousand total shares from 20 transactions

Exercise Derivative Conversion (M)

66.3 Thousand total shares from 7 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BREGE LAURA

  • Director
0 2020-07-02 2

RIKER LAUREN BULLARO VICE PRESIDENT, FINANCE

  • Officer
12,633 2020-06-29 9

LARANJEIRA CHARLES ANTHONY SVP, TECHNICAL OPERATIONS

  • Officer
20,250 2020-06-29 3

SCIBETTA JAMES S

  • Director
621,158 2020-06-23 0

GORDON CARL L

  • Director
  • 10% Owner
12,714,404 2020-06-19 0

PACE GARY W

  • Director
0 2020-06-17 2

STACK DAVID M

  • Director
0 2020-06-11 10

MIDDLETON FRED A

  • Director
0 2020-06-11 0

LONGENECKER JOHN P PHD

  • Director
17,757 2020-06-09 3

HASTINGS PAUL J

  • Director
6,116 2020-06-09 2

KRONENFELD MARK A.

  • Director
15,671 2020-06-09 1

GREENSTREET YVONNE

  • Director
11,021 2020-06-09 1

WILLIAMS KRISTEN MARIE CHIEF ADMINISTRATIVE OFFICER

  • Officer
24,887 2020-06-09 3

BRAUNSTEIN SCOTT

  • Director
0 2020-06-09 0

REINHART CHARLES A. III CHIEF FINANCIAL OFFICER

  • Officer
27,447 2020-06-09 2

FROIMSON MARK

  • Director
5,976 2020-06-09 2

WINSTON ROY CHIEF CLINICAL OFFICER

  • Officer
39,237 2020-06-09 2

MCLOUGHLIN DENNIS CHIEF COMMERCIAL OFFICER

  • Officer
28,898 2020-06-09 3

REINHARDT MAX PRESIDENT

  • Officer
14,000 2020-06-09 1

CHRISTIE CHRISTOPHER

  • Director
1,260 2020-06-09 3

MANNING DONALD C. CHIEF MEDICAL OFFICER

  • Officer
28,500 2020-06-02 2

PATOU GARY

  • Director
0 2020-06-01 0

EVNIN LUKE

  • Director
  • 10% Owner
0 2020-05-28 0

SCRANTON RICHARD CHIEF SCIENTIFIC OFFICER

  • Officer
16,061 2019-11-08 1

WICKI ANDREAS

  • Director
1,750,000 2019-10-07 0

WEILAND ROBERT J.

  • Director
0 2019-01-29 0

WINGER DENNIS L

  • Director
47,750 2018-08-17 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP III LLC

ISALY SAMUEL D

  • 10% Owner
5,550,000 2018-01-03 0

JONES JAMES B SVP & CHIEF MEDICAL OFFICER

  • Officer
16,823 2017-11-20 0

HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD.

  • 10% Owner
No longer subject to file 2017-09-12 0

MARKVICKA TAUNIA

  • Director
37,100 2017-05-15 0

PRATT JOHN GENERAL MANAGER, SAN DIEGO

  • Officer
No longer subject to file 2013-06-12 0

SANDERLING VENTURE PARTNERS VI LP

SANDERLING VI BETEILIGUNGS GMBH & CO KG

SANDERLING VENTURES MANAGEMENT VI

SANDERLING VI LIMITED PARTNERSHIP

SANDERLING VENTURE PARTNERS VI CO INVESTMENT FUND LP

  • 10% Owner
866,083 2013-03-15 0

SANDERLING VENTURE PARTNERS VI LP

SANDERLING VI BETEILIGUNGS GMBH & CO KG

SANDERLING VENTURES MANAGEMENT VI

SANDERLING VI LIMITED PARTNERSHIP

SANDERLING VENTURE PARTNERS VI CO INVESTMENT FUND LP

MIDDLETON FRED A

  • Director
416,083 2013-03-15 0

KAILIAN VAUGHN M

GADICKE ANSBERT

  • FORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2013-03-11 0

MPM BIOVENTURES IV QP LP

SCOPA JAMES PAUL

MPM BIOVENTURES IV GP LLC

MPM BIOVENTURES IV LLC

MPM ASSET MANAGEMENT INVESTORS BV4 LLC

MPM BIOVENTURES IV GMBH & CO. BETEILIGUNGS KG

FOLEY TODD

VANDER VORT JOHN

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2013-03-11 0

SANDERLING VENTURE PARTNERS VI LP

SANDERLING VI BETEILIGUNGS GMBH & CO KG

SANDERLING VI LIMITED PARTNERSHIP

SANDERLING VENTURE PARTNERS VI CO INVESTMENT FUND LP

  • 10% Owner
559,453 2013-03-07 0

SANDERLING VENTURE PARTNERS VI LP

SANDERLING VI BETEILIGUNGS GMBH & CO KG

SANDERLING VI LIMITED PARTNERSHIP

SANDERLING VENTURE PARTNERS VI CO INVESTMENT FUND LP

MIDDLETON FRED A

  • Director
  • 10% Owner
602,286 2013-03-07 0

SANDERLING VENTURE PARTNERS VI LP

SANDERLING VI BETEILIGUNGS GMBH & CO KG

SANDERLING VENTURES MANAGEMENT VI

SANDERLING VI LIMITED PARTNERSHIP

SANDERLING VENTURE PARTNERS IV CO INVESTMENT FUND LP

MIDDLETON FRED A

  • Director
  • 10% Owner
2,366,158 2013-01-24 0

MPM BIOVENTURES IV QP LP

MPM BIOVENTURES IV GP LLC

MPM BIOVENTURES IV LLC

MPM ASSET MANAGEMENT INVESTORS BV4 LLC

MPM BIOVENTURES IV GMBH & CO. BETEILIGUNGS KG

FOLEY TODD

VANDER VORT JOHN

SCOPA JAMES PAUL

ST PETER STEVEN

  • 10% Owner
3,290,479 2011-11-21 0

MPM BIOVENTURES IV QP LP

MPM BIOVENTURES IV GP LLC

MPM BIOVENTURES IV LLC

MPM ASSET MANAGEMENT INVESTORS BV4 LLC

MPM BIOVENTURES IV GMBH & CO. BETEILIGUNGS KG

DOMBKOWSKI ASHLEY L

VANDER VORT JOHN

SCOPA JAMES PAUL

ST PETER STEVEN

GREENE WILLIAM

  • 10% Owner
2,828,941 2011-02-08 0

WALTERS MARK SVP, TECHNICNICAL OPERATIONS

  • Officer
0 2011-02-02 0

LAMBERT WILLIAM SVP, PHARMACEUTICAL DEV

  • Officer
0 2011-02-02 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

RIKER LAUREN BULLARO - Officer VICE PRESIDENT, FINANCE

2020-06-29 S 2,000 $48.72 d 16,633 12,633.00 direct yes

LARANJEIRA CHARLES ANTHONY - Officer SVP, TECHNICAL OPERATIONS

2020-06-29 M 7,500 d 22,500 20,250.00 direct

LARANJEIRA CHARLES ANTHONY - Officer SVP, TECHNICAL OPERATIONS

2020-06-29 S 1,778 $52.03 d 20,250 20,250.00 direct yes

LARANJEIRA CHARLES ANTHONY - Officer SVP, TECHNICAL OPERATIONS

2020-06-29 M 30,000 $44.10 a 80,351 20,250.00 direct yes

LARANJEIRA CHARLES ANTHONY - Officer SVP, TECHNICAL OPERATIONS

2020-06-29 M 3,750 $37.81 a 27,851 20,250.00 direct yes

RIKER LAUREN BULLARO - Officer VICE PRESIDENT, FINANCE

2020-06-29 S 2,000 $50.34 d 12,633 12,633.00 direct yes

RIKER LAUREN BULLARO - Officer VICE PRESIDENT, FINANCE

2020-06-29 M 6,000 $10.34 a 18,633 12,633.00 direct yes

LARANJEIRA CHARLES ANTHONY - Officer SVP, TECHNICAL OPERATIONS

2020-06-29 M 15,000 d 15,000 20,250.00 direct

LARANJEIRA CHARLES ANTHONY - Officer SVP, TECHNICAL OPERATIONS

2020-06-29 S 6,859 $51.77 d 22,028 20,250.00 direct yes

LARANJEIRA CHARLES ANTHONY - Officer SVP, TECHNICAL OPERATIONS

2020-06-29 M 7,500 $43.54 a 50,351 20,250.00 direct yes

RIKER LAUREN BULLARO - Officer VICE PRESIDENT, FINANCE

2020-06-29 S 2,000 $49.34 d 14,633 12,633.00 direct yes

LARANJEIRA CHARLES ANTHONY - Officer SVP, TECHNICAL OPERATIONS

2020-06-29 M 30,000 d 10,000 20,250.00 direct

LARANJEIRA CHARLES ANTHONY - Officer SVP, TECHNICAL OPERATIONS

2020-06-29 M 3,750 d 6,250 20,250.00 direct

LARANJEIRA CHARLES ANTHONY - Officer SVP, TECHNICAL OPERATIONS

2020-06-29 S 51,464 $50.01 d 28,887 20,250.00 direct yes

LARANJEIRA CHARLES ANTHONY - Officer SVP, TECHNICAL OPERATIONS

2020-06-29 M 15,000 $38.35 a 42,851 20,250.00 direct yes

RIKER LAUREN BULLARO - Officer VICE PRESIDENT, FINANCE

2020-06-29 M 6,000 d 8,180 12,633.00 direct

CHRISTIE CHRISTOPHER - Director

2020-06-09 A 1,260 a 1,260 1,260.00 direct

GREENSTREET YVONNE - Director

2020-06-09 A 8,027 a 8,027 11,021.00 direct

HASTINGS PAUL J - Director

2020-06-09 A 1,260 a 6,116 6,116.00 direct

LONGENECKER JOHN P PHD - Director

2020-06-09 A 8,027 a 8,027 17,757.00 direct

PACE GARY W - Director

2020-06-09 A 1,260 a 59,949 59,949.00 direct

MCLOUGHLIN DENNIS - Officer CHIEF COMMERCIAL OFFICER

2020-06-09 A 35,000 a 35,000 28,898.00 direct

REINHARDT MAX - Officer PRESIDENT

2020-06-09 A 14,000 a 14,000 14,000.00 direct

RIKER LAUREN BULLARO - Officer VICE PRESIDENT, FINANCE

2020-06-09 A 12,000 a 12,000 12,633.00 direct

STACK DAVID M - Director - Officer CEO AND CHAIRMAN

2020-06-09 A 33,300 a 200,209 220,013.00 direct

WINSTON ROY - Officer CHIEF CLINICAL OFFICER

2020-06-09 A 35,000 a 35,000 39,237.00 direct

BREGE LAURA - Director

2020-06-09 A 1,260 a 7,921 7,921.00 direct

FROIMSON MARK - Director

2020-06-09 A 8,027 a 8,027 5,976.00 direct

GREENSTREET YVONNE - Director

2020-06-09 A 1,260 a 11,021 11,021.00 direct

KRONENFELD MARK A. - Director

2020-06-09 A 8,027 a 8,027 15,671.00 direct

LONGENECKER JOHN P PHD - Director

2020-06-09 A 1,260 a 17,757 17,757.00 direct

LARANJEIRA CHARLES ANTHONY - Officer SVP, TECHNICAL OPERATIONS

2020-06-09 A 35,000 a 35,000 24,101.00 direct

MCLOUGHLIN DENNIS - Officer CHIEF COMMERCIAL OFFICER

2020-06-09 A 14,000 a 28,898 28,898.00 direct

REINHART CHARLES A. III - Officer CHIEF FINANCIAL OFFICER

2020-06-09 A 31,500 a 31,500 27,447.00 direct

RIKER LAUREN BULLARO - Officer VICE PRESIDENT, FINANCE

2020-06-09 A 4,800 a 12,633 12,633.00 direct

WILLIAMS KRISTEN MARIE - Officer CHIEF ADMINISTRATIVE OFFICER

2020-06-09 A 35,000 a 35,000 24,887.00 direct

WINSTON ROY - Officer CHIEF CLINICAL OFFICER

2020-06-09 A 14,000 a 39,237 39,237.00 direct

CHRISTIE CHRISTOPHER - Director

2020-06-09 A 8,027 a 8,027 1,260.00 direct

FROIMSON MARK - Director

2020-06-09 A 1,260 a 5,976 5,976.00 direct

HASTINGS PAUL J - Director

2020-06-09 A 8,027 a 8,027 6,116.00 direct

KRONENFELD MARK A. - Director

2020-06-09 A 1,260 a 15,671 15,671.00 direct

PACE GARY W - Director

2020-06-09 A 8,027 a 8,027 59,949.00 direct

LARANJEIRA CHARLES ANTHONY - Officer SVP, TECHNICAL OPERATIONS

2020-06-09 A 14,000 a 24,101 24,101.00 direct

REINHARDT MAX - Officer PRESIDENT

2020-06-09 A 35,000 a 35,000 14,000.00 direct

REINHART CHARLES A. III - Officer CHIEF FINANCIAL OFFICER

2020-06-09 A 12,600 a 27,447 27,447.00 direct

STACK DAVID M - Director - Officer CEO AND CHAIRMAN

2020-06-09 A 275,000 a 275,000 220,013.00 direct

WILLIAMS KRISTEN MARIE - Officer CHIEF ADMINISTRATIVE OFFICER

2020-06-09 A 14,000 a 24,887 24,887.00 direct

BREGE LAURA - Director

2020-06-09 A 8,027 a 8,027 7,921.00 direct

STACK DAVID M - Director - Officer CEO AND CHAIRMAN

2020-06-08 S 1,721 $48.49 d 166,909 186,713.00 direct

STACK DAVID M - Director - Officer CEO AND CHAIRMAN

2020-06-08 S 15,390 $48.08 d 168,630 186,713.00 direct

BREGE LAURA - Director

2020-06-05 S 2,100 $48.70 d 6,661 6,661.00 direct

RIKER LAUREN BULLARO - Officer VICE PRESIDENT, FINANCE

2020-06-05 S 1,752 $48.37 d 7,833 7,833.00 direct

WILLIAMS KRISTEN MARIE - Officer CHIEF ADMINISTRATIVE OFFICER

2020-06-05 S 5,904 $48.61 d 10,887 10,887.00 direct

REINHART CHARLES A. III - Officer CHIEF FINANCIAL OFFICER

2020-06-04 S 1,489 $46.33 d 14,847 14,847.00 direct

WILLIAMS KRISTEN MARIE - Officer CHIEF ADMINISTRATIVE OFFICER

2020-06-04 S 2,402 $46.33 d 16,791 10,887.00 direct

STACK DAVID M - Director - Officer CEO AND CHAIRMAN

2020-06-04 S 14,314 $46.33 d 184,020 186,713.00 direct

MCLOUGHLIN DENNIS - Officer CHIEF COMMERCIAL OFFICER

2020-06-04 S 1,447 $46.33 d 14,898 14,898.00 direct

HASTINGS PAUL J - Director

2020-06-04 S 2,025 $47.46 d 4,856 4,856.00 direct

RIKER LAUREN BULLARO - Officer VICE PRESIDENT, FINANCE

2020-06-04 S 879 $46.33 d 9,585 7,833.00 direct

LARANJEIRA CHARLES ANTHONY - Officer SVP, TECHNICAL OPERATIONS

2020-06-04 S 863 $46.33 d 10,101 10,101.00 direct

MANNING DONALD C. - Officer CHIEF MEDICAL OFFICER

2020-06-02 A 71,300 a 71,300 28,500.00 direct

MANNING DONALD C. - Officer CHIEF MEDICAL OFFICER

2020-06-02 A 28,500 a 28,500 28,500.00 direct

RIKER LAUREN BULLARO - Officer VICE PRESIDENT, FINANCE

2020-05-21 M 2,000 d 14,180 10,464.00 direct

RIKER LAUREN BULLARO - Officer VICE PRESIDENT, FINANCE

2020-05-21 M 2,000 $10.34 a 12,464 10,464.00 direct

RIKER LAUREN BULLARO - Officer VICE PRESIDENT, FINANCE

2020-05-21 S 2,000 $45.26 d 10,464 10,464.00 direct

RIKER LAUREN BULLARO - Officer VICE PRESIDENT, FINANCE

2020-05-19 M 2,000 $10.34 a 12,464 10,464.00 direct

RIKER LAUREN BULLARO - Officer VICE PRESIDENT, FINANCE

2020-05-19 M 2,000 d 16,180 10,464.00 direct

RIKER LAUREN BULLARO - Officer VICE PRESIDENT, FINANCE

2020-05-19 S 2,000 $42.81 d 10,464 10,464.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments